Syngenta made public an interview made by Mr Démaré, Chairman of the Board, to reassert the group’s view that Monsanto’s bid should be rejected. The main elements remain unchanged (the so-called "under-valuation" of Syngenta, the significant execution risks and the "damage" to Syngenta’s integrated business). Also, Démaré insists Monsanto has had a purely opportunistic approach, given Syngenta’s current share price weakness, in making its of
23 Jun 2015
Syngenta in defence mode
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Syngenta in defence mode
Syngenta made public an interview made by Mr Démaré, Chairman of the Board, to reassert the group’s view that Monsanto’s bid should be rejected. The main elements remain unchanged (the so-called "under-valuation" of Syngenta, the significant execution risks and the "damage" to Syngenta’s integrated business). Also, Démaré insists Monsanto has had a purely opportunistic approach, given Syngenta’s current share price weakness, in making its of